In addition, it addresses the FDA’s communications With all the applicant, the retention of data that help the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of an SE report to a different applicant and Digital submission on the SE report and amendments